PDF
File
Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
- New shares from the exercise of Brain+ warrants of series TO 3 have been registered with the Danish Business Authority (DA: Erhvervsstyrelsen)
- Brain+ interim shares (IA/midlertidig aktie) will be converted into common shares and commence trading on Nasdaq First North Copenhagen on April 11, 2024
- Registration and commencement of trading of shares from the directed issue will be separate
Copenhagen, Denmark, April 10, 2024 - Brain+ A/S (Nasdaq First North: BRAINP)
On 26 March, Brain+ A/S ("Brain+" or "the Company") announced the outcome of the exercise of warrants of series TO 3 (the "Warrants"), which were issued in connection with the Company's unit rights issue in May 2023. In connection with the Warrant exercise, Brain+ also carried out a directed issue to guarantors of the Warrant exercise (the "Directed Issue"). The new shares from the Warrant exercise have now been registered with the Danish Business Authority. Registration of shares from the Directed Issue will follow.
After the completion and registration of the Warrant exercise with the Danish Business Authority, the number of shares in Brain+ have increased by 18,198,975 shares, from 65,462,430 shares to 83,661,405 shares, and the Company's nominal share capital have increased by DKK 1,819,897.50, from DKK 6,546,243.00 to DKK 8,366,140.50. The shares issued to guarantors of the of the Warrant exercise in a Directed Issue are not part of the above numbers.
The conversion from interim shares to common shares in Brain+ from the Warrant exercise will be made on April 10, 2024. Application has been made to Nasdaq Copenhagen A/S for the new shares to be admitted for trading on Nasdaq First North Copenhagen. It is expected that the first day of trading of the new shares will be on April 11, 2024.
Directed issue to guarantors
The Directed Issue of new shares to guarantors will be registered with the Danish Business Authority separately from the shares from the Warrant exercise. Upon registration of shares from the Directed Issue, the number of shares in Brain+ will increase with additionally 7,787,874 shares, from 83,661,405 shares to 91,449,279 shares, and the Company's nominal share capital will increase by DKK 778,787.40, from DKK 8,366,140.50 to 9,144,927.90.
Information on the date for registration of the new shares from the Directed Issue and the first day of trading of these shares on Nasdaq First North Copenhagen will be communicated in a separate announcement within the coming days.
Advisors
In connection with the unit rights issue including the issue and exercise of warrants of series TO 3, Sedermera Corporate Finance AB and Gemstone Capital A/S have acted as financial advisors to Brain+. Markets & Corporate Law Nordic AB acted as legal advisor. Nordic Issuing AB is the issuing agent.
For more information about the warrant exercise, please contact:
Sedermera Corporate Finance AB
Phone: +46 (0) 40 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se
Gemstone Capital A/S
Phone: +45 33 22 07 00
E-mail: sh@gemstonecapital.com
www.gemstonecapital.com
For more information about Brain+, please contact:
Kim Baden-Kristensen, CEO
Phone: +45 31 39 33 17
E-mail: kim@brain-plus.com
www.brain-plus.com
Certified Adviser
Keswick Global AG
Phone: +43 1 740 408 045
E-mail: info@keswickglobal.com